APO (APO) Form 144 discloses planned sale of 3M shares worth $396M

Rhea-AI Filing Summary

A shareholder of APO has filed a notice of proposed sale under Rule 144 covering 3,000,000 shares of common stock. The shares are to be sold through Wells Fargo Securities, LLC on the NYSE, with an indicated aggregate market value of $396,240,000.00. The filing notes that 580,422,573 shares of the same class were outstanding and lists an approximate sale date of 12/03/2025. The shares were acquired on 12/01/2025 as a contribution from Socrates Trust, with the original acquisition by the donor dated 01/01/2022 as merger consideration.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Wells Fargo Securities, LLC 30 Hudson Yards, 14th Floor New York NY 10001	3000000	396240000.00	580422573	12/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	12/01/2025	Contribution from parent	Socrates Trust		01/01/2022	3000000	01/01/2022	Merger consideration

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many APO shares are proposed to be sold under this Form 144?

The filing covers a proposed sale of 3,000,000 shares of APO common stock.

What is the aggregate market value of the APO shares in this Form 144?

The aggregate market value of the shares covered by the notice is listed as $396,240,000.00.

Which broker is handling the proposed APO share sale?

The proposed sale of APO common stock is to be executed through Wells Fargo Securities, LLC, located at 30 Hudson Yards, 14th Floor, New York, NY 10001.

On which exchange are the APO shares expected to be sold and when?

The shares are expected to be sold on the NYSE with an approximate sale date of 12/03/2025.

How does the proposed APO share sale compare to shares outstanding?

The notice states that there were 580,422,573 shares of APO common stock outstanding at the time referenced, while 3,000,000 shares are covered by this proposed sale.

How and when were the APO shares in this Form 144 acquired?

The 3,000,000 shares were acquired on 12/01/2025 via a contribution from parent by Socrates Trust, with the donor originally acquiring the securities on 01/01/2022 as merger consideration.

What representation does the seller make in this APO Form 144 filing?

The person on whose behalf the shares are to be sold represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.